Clinical Trial

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Stereotactic Body Radiation Therapy(SBRT) for spinal metastases has been proved a good results in pain relieve and local control, However,the longterm of efficacy and safety of this regimen is unclear.The purpose of the study is to evaluate the longterm outcome of this therapeutic regimen in selective patients who will be survival more than 2 years.
Trial Details
NCT Number NCT03392233
Lead Sponsor RenJi Hospital
Conditions Breast Cancer, Prostate Cancer, Non Small Cell Lung Cancer
Enrollment 100 participants
Start Date 2017-08-18
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2018-01-05